Ladina Christoffel, Ralf Bends, David Toub, Sven Schiermeier, Gregor Pschadka, Matthias Engelhardt, Stephen Quinn, Michael Hartmann, Marwan Habiba, Ricardo Felberbaum, Anke Brössner, Cordula Schippert, Thomas Römer
Objective: To describe pregnancy outcomes in women who conceived after undergoing transcervical fibroid ablation (TFA) as treatment for symptomatic uterine fibroids. Materials and Methods: TFA was used to treat symptomatic uterine fibroids with radiofrequency energy, both under clinical trial protocol and commercial usage in hospitals in Europe, the United Kingdom, Mexico, and the United States. All women who reported pregnancies to their physicians after undergoing TFA with the Sonata® System and provided consent for use of their data were included...
June 1, 2022: Journal of Gynecologic Surgery